|
|
| |
|
|
| |
Dispensing health care products in a community pharmacy (medicines and medical devices), whether or not with a prescription, attempts to ensure mutual compatibility of products ( art. R.5015-48 of the French Public Health Code (PHC)
),
and their suitability for the patient
( art. R.5015-60 et
L.5125-23 of the PHC), and finally to give relevant advice.
The analysis of the demand (with or without a prescription) is a complex process.
This process may conclude by: |
|
|
|
| Generally and up to the present, this analysis process left traces in the community pharmacy only in a few cases: |
|
delivery was rendered formal either legally by listing in the prescription register (for products on lists I & II, narcotics and preparations) or in an accounting sense by payment, |
|
 |
delivery refusal was mentioned only on the prescription. |
|
|
| When dispensing is complex (regulatory incident, therapeutic doubt, dangerous interactions or contraindications, original intervention,…) it becomes indispensable to make sure that the pharmaceutical act : |
|
is understandable : (state the thoughts from questioning the patient, the physician, and in some conditions even the person picking up the prescription) |
|
 |
is stored : (ensure the description of the act, patient follow-up…) |
|
 |
can be traced : (find the author of a delivery, of a prescription, find a product, evaluate acts, notify special cases) |
|
 |
can be defended : (justify an act faced with the patient, the physician, courts). |
|
| |
| To place value on dispensing, the essential function of the pharmacist, place value on the pharmacy, which guarantees safety in care, to prepare the future with respect to therapeutic and regulatory challenges: these are the functions of the Pharmaceutical Opinion. |
|
|
 |
| Diagram of the process |
 |
 |
| |
|